-
1
-
-
30044441045
-
Bladder cancer: Epidemiology, staging and grading, and diagnosis
-
DOI 10.1016/j.urology.2005.07.062, PII S0090429505014901
-
Kirkali Z., Chan T., Manoharan M., Algaba F., Busch C., Cheng L., Kiemeney L., Kriegmair M., Montironi R., Murphy W. M., Sesterhenn I. A., Tachibana M., Weider J., Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 2005 66 6, supplement 4 34 (Pubitemid 43049607)
-
(2005)
Urology
, vol.66
, Issue.6 SUPPL. 1
, pp. 4-34
-
-
Kirkali, Z.1
Chan, T.2
Manoharan, M.3
Algaba, F.4
Busch, C.5
Cheng, L.6
Kiemeney, L.7
Kriegmair, M.8
Montironi, R.9
Murphy, W.M.10
Sesterhenn, I.A.11
Tachibana, M.12
Weider, J.13
-
2
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
DOI 10.1093/annonc/mdl498
-
Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P., Estimates of the cancer incidence and mortality in Europe in 2006 Annals of Oncology 2007 18 3 581 592 (Pubitemid 46359643)
-
(2007)
Annals of Oncology
, vol.18
, Issue.3
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
Heanue, M.4
Colombet, M.5
Boyle, P.6
-
3
-
-
26944439457
-
Occupational bladder cancer: From cohort study to biologic molecular marker
-
Matsumoto K., Irie A., Satoh T., Kuruma H., Arakawa T., Baba S., Occupational bladder cancer: from cohort study to biologic molecular marker Medical Science Monitor 2005 11 10 RA311 RA315
-
(2005)
Medical Science Monitor
, vol.11
, Issue.10
-
-
Matsumoto, K.1
Irie, A.2
Satoh, T.3
Kuruma, H.4
Arakawa, T.5
Baba, S.6
-
4
-
-
12544256265
-
The economic consequences of prostate and bladder cancer in the UK
-
DOI 10.1111/j.1464-410X.2005.05249.x
-
Sangar V. K., Ragavan N., Matanhelia S. S., Watson M. W., Blades R. A., The economic consequences of prostate and bladder cancer in the UK BJU International 2005 95 1 59 63 (Pubitemid 350020870)
-
(2005)
BJU International, Supplement
, vol.95
, Issue.1
, pp. 59-63
-
-
Sangar, V.K.1
Ragavan, N.2
Matanhelia, S.S.3
Watson, M.W.4
Blades, R.A.5
-
5
-
-
43849088953
-
Bladder cancer: A major public health issue
-
Grasso M., Bladder cancer: a major public health issue European Urology, Supplements 2008 7 7 510 515
-
(2008)
European Urology, Supplements
, vol.7
, Issue.7
, pp. 510-515
-
-
Grasso, M.1
-
6
-
-
32944465832
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
-
DOI 10.1016/j.eururo.2005.12.031, PII S0302283805008523
-
Sylvester R. J., Van Der Meijden A. P. M., Oosterlinck W., Witjes J. A., Bouffioux C., Denis L., Newling D. W. W., Kurth K., Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials European Urology 2006 49 3 466 475 (Pubitemid 43259554)
-
(2006)
European Urology
, vol.49
, Issue.3
, pp. 466-475
-
-
Sylvester, R.J.1
Van Der Meijden, A.P.M.2
Oosterlinck, W.3
Witjes, J.A.4
Bouffioux, C.5
Denis, L.6
Newling, D.W.W.7
Kurth, K.8
-
7
-
-
33846635592
-
Muscle-Invasive Urothelial Carcinoma of the Bladder
-
DOI 10.1016/j.urology.2006.09.028, PII S009042950602454X
-
Malkowicz S. B., van Poppel H., Mickisch G., Pansadoro V., Throff J., Soloway M. S., Chang S., Benson M., Fukui I., Muscle-invasive urothelial carcinoma of the bladder Urology 2007 69 1, supplement 3 16 (Pubitemid 46186483)
-
(2007)
Urology
, vol.69
, Issue.1 SUPPL.
, pp. 3-16
-
-
Malkowicz, S.B.1
Van Poppel, H.2
Mickisch, G.3
Pansadoro, V.4
Thuroff, J.5
Soloway, M.S.6
Chang, S.7
Benson, M.8
Fukui, I.9
-
8
-
-
0037366062
-
Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder
-
DOI 10.1097/01.ju.0000043638.89552.ed
-
Shariat S. F., Kim J. H., Ayala G. E., Kho K., Wheeler T. M., Lerner S. P., Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder Journal of Urology 2003 169 3 938 942 (Pubitemid 36188129)
-
(2003)
Journal of Urology
, vol.169
, Issue.3
, pp. 938-942
-
-
Shariat, S.F.1
Kim, J.-H.2
Ayala, G.E.3
Kho, K.4
Wheeler, T.M.5
Lerner, S.P.6
-
9
-
-
33746370696
-
Molecular genetics of bladder cancer: Targets for diagnosis and therapy
-
Baffa R., Letko J., McClung C., LeNoir J., Vecchione A., Gomella L. G., Molecular genetics of bladder cancer: targets for diagnosis and therapy Journal of Experimental and Clinical Cancer Research 2006 25 2 145 160 (Pubitemid 44113858)
-
(2006)
Journal of Experimental and Clinical Cancer Research
, vol.25
, Issue.2
, pp. 145-160
-
-
Baffa, R.1
Letko, J.2
McClung, C.3
LeNoir, J.4
Vecchione, A.5
Gomella, L.G.6
-
10
-
-
36249004425
-
The genetics of bladder cancer: A cytogeneticist's perspective
-
DOI 10.1159/000108298
-
Wolff D. J., The genetics of bladder cancer: a cytogeneticist's perspective Cytogenetic and Genome Research 2007 118 24 177 181 (Pubitemid 350125254)
-
(2007)
Cytogenetic and Genome Research
, vol.118
, Issue.2-4
, pp. 177-181
-
-
Wolff, D.J.1
-
11
-
-
60349104574
-
Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer
-
Ahirwar D., Mandhani A., Mittal R. D., Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer Archives of Medical Research 2009 40 2 97 102
-
(2009)
Archives of Medical Research
, vol.40
, Issue.2
, pp. 97-102
-
-
Ahirwar, D.1
Mandhani, A.2
Mittal, R.D.3
-
12
-
-
34547578958
-
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
-
Harris R. E., Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer Sub-Cellular Biochemistry 2007 42 93 126
-
(2007)
Sub-Cellular Biochemistry
, vol.42
, pp. 93-126
-
-
Harris, R.E.1
-
13
-
-
0034062380
-
Cyclo-oxygenase isoenzymes: Physiological and pharmacological role
-
DOI 10.1046/j.1365-2044.2000.01271.x
-
Kam P. C. A., See A. U. L., Cyclo-oxygenase isoenzymes: physiological and pharmacological role Anaesthesia 2000 55 5 442 449 (Pubitemid 30301443)
-
(2000)
Anaesthesia
, vol.55
, Issue.5
, pp. 442-449
-
-
Kam, P.C.A.1
See, A.U.-L.2
-
14
-
-
67650065464
-
Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer
-
Di J. M., Zhou J., Zhou X. L., Gao X., Shao C. Q., Pang J., Sun QI. P., Zhang Y., Ruan X. X., Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer Archives of Medical Research 2009 40 4 268 275
-
(2009)
Archives of Medical Research
, vol.40
, Issue.4
, pp. 268-275
-
-
Di, J.M.1
Zhou, J.2
Zhou, X.L.3
Gao, X.4
Shao, C.Q.5
Pang, J.6
Sun, Q.I.P.7
Zhang, Y.8
Ruan, X.X.9
-
15
-
-
33745932131
-
Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways
-
DOI 10.1097/00008469-200608000-00005, PII 0000846920060800000005
-
Sengupta A., Ghosh S., Das R. K., Bhattacharjee S., Bhattacharya S., Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways European Journal of Cancer Prevention 2006 15 4 301 305 (Pubitemid 44060487)
-
(2006)
European Journal of Cancer Prevention
, vol.15
, Issue.4
, pp. 301-305
-
-
Sengupta, A.1
Ghosh, S.2
Das, R.K.3
Bhattacharjee, S.4
Bhattacharya, S.5
-
16
-
-
34147221918
-
MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats
-
DOI 10.1148/radiol.2431050658
-
Fournier L. S., Novikov V., Lucidi V., Fu Y., Miller T., Floyd E., Shames D. M., Brasch R. C., MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats Radiology 2007 243 1 105 111 (Pubitemid 46579700)
-
(2007)
Radiology
, vol.243
, Issue.1
, pp. 105-111
-
-
Fournier, L.S.1
Novikov, V.2
Lucidi, V.3
Fu, Y.4
Miller, T.5
Floyd, E.6
Shames, D.M.7
Brasch, R.C.8
-
17
-
-
0342369370
-
Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer
-
Stockbrgger R. W., Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer European Journal of Cancer Prevention 1999 8 1, supplement S21 S25
-
(1999)
European Journal of Cancer Prevention
, vol.8
, Issue.1 SUPPL.
-
-
Stockbrgger, R.W.1
-
18
-
-
0033401645
-
Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
-
Kitayama W., Denda A., Okajima E., Tsujiuchi T., Konishi Y., Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Carcinogenesis 1999 20 12 2305 2310 (Pubitemid 30015903)
-
(1999)
Carcinogenesis
, vol.20
, Issue.12
, pp. 2305-2310
-
-
Kitayama, W.1
Denda, A.2
Okajima, E.3
Tsujiuchi, T.4
Konishi, Y.5
-
19
-
-
0034099597
-
Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder
-
Shirahama T., Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder Clinical Cancer Research 2000 6 6 2424 2430 (Pubitemid 30399211)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.6
, pp. 2424-2430
-
-
Shirahama, T.1
-
20
-
-
0035109236
-
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder
-
Ristimki A., Nieminen O., Saukkonen K., Hotakainen K., Nordling S., Haglund C., Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder American Journal of Pathology 2001 158 3 849 853 (Pubitemid 32221778)
-
(2001)
American Journal of Pathology
, vol.158
, Issue.3
, pp. 849-853
-
-
Ristimaki, A.1
Nieminen, O.2
Saukkonen, K.3
Hotakainen, K.4
Nordling, S.5
Haglund, C.6
-
21
-
-
16444380637
-
Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression
-
DOI 10.1158/0008-5472.CAN-04-3567
-
Klein R. D., Van Pelt C. S., Sabichi A. L., Dela Cerda J., Fischer S. M., Frstenberger G., Mller-Decker K., Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression Cancer Research 2005 65 5 1808 1813 (Pubitemid 40478608)
-
(2005)
Cancer Research
, vol.65
, Issue.5
, pp. 1808-1813
-
-
Klein, R.D.1
Van Pelt, C.S.2
Sabichi, A.L.3
Dela Cerda, J.4
Fischer, S.M.5
Furstenberger, G.6
Muller-Decker, K.7
-
22
-
-
70350306703
-
Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis
-
Parada B., Sereno J., Reis F., Teixeira-Lemos E., Garrido P., Pinto A. F., Cunha M. F., Pinto R., Mota A., Figueiredo A., Teixeira F., Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis Cancer Biology and Therapy 2009 8 17 1615 1622
-
(2009)
Cancer Biology and Therapy
, vol.8
, Issue.17
, pp. 1615-1622
-
-
Parada, B.1
Sereno, J.2
Reis, F.3
Teixeira-Lemos, E.4
Garrido, P.5
Pinto, A.F.6
Cunha, M.F.7
Pinto, R.8
Mota, A.9
Figueiredo, A.10
Teixeira, F.11
-
23
-
-
0017228708
-
Histological classification of urinary bladder cancers in rats induced by N butyl N (4 hydroxybutyl)nitrosamine
-
Fukushima S., Hirose M., Tsuda H., Histological classification of urinary bladder cancers in rats induced by N butyl N (4 hydroxybutyl)nitrosamine Gann, The Japanese Journal of Cancer Research 1976 67 1 81 90
-
(1976)
Gann, the Japanese Journal of Cancer Research
, vol.67
, Issue.1
, pp. 81-90
-
-
Fukushima, S.1
Hirose, M.2
Tsuda, H.3
-
24
-
-
15744398205
-
Preneoplastic lesions and conditions of the urinary bladder
-
DOI 10.1016/S1570-9124(03)00023-0
-
Montironi R., Mazzucchelli R., Preneoplastic lesions and conditions of the urinary bladder EAU Update Series 2003 1 2 53 63 (Pubitemid 40411073)
-
(2003)
EAU Update Series
, vol.1
, Issue.2
, pp. 53-63
-
-
Montironi, R.1
Mazzucchelli, R.2
-
25
-
-
45949086655
-
Tumors of the urinary system: Non-invasive urothelial neoplasias
-
Lyon, France IARCC Press
-
Sauter G., Algaba F., Amin M., Eble J. N., Sauter G., Epstein J. L., Sesterhenn I., Tumors of the urinary system: non-invasive urothelial neoplasias WHO Classification of Tumors of the Urinary System and Male Genital Organs 2004 Lyon, France IARCC Press 29 34
-
(2004)
WHO Classification of Tumors of the Urinary System and Male Genital Organs
, pp. 29-34
-
-
Sauter, G.1
Algaba, F.2
Amin, M.3
Eble, J.N.4
Sauter, G.5
Epstein, J.L.6
Sesterhenn, I.7
-
26
-
-
32044443426
-
Prevention of bladder cancer: A review
-
DOI 10.1016/j.eururo.2005.12.011, PII S0302283805008286
-
Leppert J. T., Shvarts O., Kawaoka K., Lieberman R., Belldegrun A. S., Pantuck A. J., Prevention of bladder cancer: a review European Urology 2006 49 2 226 234 (Pubitemid 43197858)
-
(2006)
European Urology
, vol.49
, Issue.2
, pp. 226-234
-
-
Leppert, J.T.1
Shvarts, O.2
Kawaoka, K.3
Lieberman, R.4
Belldegrun, A.S.5
Pantuck, A.J.6
-
27
-
-
34548392967
-
Optimizacin de un mtodo para la determinacin de la peroxidacin lipidica en suero humano
-
Estepa V., Rdenas S., Martn M. C., Optimizacin de un mtodo para la determinacin de la peroxidacin lipidica en suero humano Anales de la Real Academia de Farmacia 2001 67 3 1 17
-
(2001)
Anales de la Real Academia de Farmacia
, vol.67
, Issue.3
, pp. 1-17
-
-
Estepa, V.1
Rdenas, S.2
Martn, M.C.3
-
28
-
-
0030586361
-
The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay
-
Benzie I. F. F., Strain J. J., The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay Analytical Biochemistry 1996 239 1 70 76
-
(1996)
Analytical Biochemistry
, vol.239
, Issue.1
, pp. 70-76
-
-
Benzie, I.F.F.1
Strain, J.J.2
-
29
-
-
0034667354
-
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
-
Grubbs C. J., Lubet R. A., Koki A. T., Leahy K. M., Masferrer J. L., Steele V. E., Kelloff G. J., Hill D. L., Seibert K., Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats Cancer Research 2000 60 20 5599 5602
-
(2000)
Cancer Research
, vol.60
, Issue.20
, pp. 5599-5602
-
-
Grubbs, C.J.1
Lubet, R.A.2
Koki, A.T.3
Leahy, K.M.4
Masferrer, J.L.5
Steele, V.E.6
Kelloff, G.J.7
Hill, D.L.8
Seibert, K.9
-
30
-
-
34548125720
-
Anti-inflammatory and side effects of cyclooxygenase inhibitors
-
Sleyman H., Demircan B., Karagz Y., Anti-inflammatory and side effects of cyclooxygenase inhibitors Pharmacological Reports 2007 59 3 247 258 (Pubitemid 47299726)
-
(2007)
Pharmacological Reports
, vol.59
, Issue.3
, pp. 247-258
-
-
Suleyman, H.1
Demircan, B.2
Karagoz, Y.3
-
31
-
-
0034646688
-
The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
-
DOI 10.1074/jbc.275.15.11397
-
Hsu A. L., Ching T. T., Wang D. S., Song X., Rangnekar V. M., Chen C. S., The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 The Journal of Biological Chemistry 2000 275 15 11397 11403 (Pubitemid 30212792)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.15
, pp. 11397-11403
-
-
Hsu, A.-L.1
Ching, T.-T.2
Wang, D.-S.3
Song, X.4
Rangnekar, V.M.5
Chen, C.-S.6
-
32
-
-
0037123345
-
Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells
-
Song X., Lin H. P., Johnson A. J., Tseng P. H., Yang Y. T., Kulp S. K., Chen C. S., Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells Journal of the National Cancer Institute 2002 94 8 585 591 (Pubitemid 34498645)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.8
, pp. 585-591
-
-
Song, X.1
Lin, H.-P.2
Johnson, A.J.3
Tseng, P.-H.4
Yang, Y.-T.5
Kulp, S.K.6
Chen, C.-S.7
-
33
-
-
0001501848
-
Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
-
Liu X. H., Kirschenbaum A., Yao S., Lee R., Holland J. F., Levine A. C., Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo Journal of Urology 2000 164 3 820 825 (Pubitemid 30637640)
-
(2000)
Journal of Urology
, vol.164
, Issue.3
, pp. 820-825
-
-
Liu, X.H.1
Kirschenbaum, A.2
Yao, S.3
Lee, R.4
Holland, J.F.5
Levine, A.C.6
-
34
-
-
0041833663
-
Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: Effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s)
-
Narayanan B. A., Condon M. S., Bosland M. C., Narayanan N. K., Reddy B. S., Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s) Clinical Cancer Research 2003 9 9 3503 3513 (Pubitemid 37082750)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.9
, pp. 3503-3513
-
-
Narayanan, B.A.1
Condon, M.S.2
Bosland, M.C.3
Narayanan, N.K.4
Reddy, B.S.5
-
35
-
-
33745648487
-
Celecoxib Inhibits Cellular Growth, Decreases Ki-67 Expression and Modifies Apoptosis in Ovarian Cancer Cell Lines
-
DOI 10.1016/j.arcmed.2005.11.014, PII S0188440906000841
-
Vital-Reyes V., Rodrguez-Burford C., Chhieng D. C., Oelschlager D. K., Reyes-Fuentes A., Barnes M., Grizzle W. E., Celecoxib inhibits cellular growth, decreases Ki-67 expression and modifies apoptosis in ovarian cancer cell lines Archives of Medical Research 2006 37 6 689 695 (Pubitemid 43975166)
-
(2006)
Archives of Medical Research
, vol.37
, Issue.6
, pp. 689-695
-
-
Vital-Reyes, V.1
Rodriguez-Burford, C.2
Chhieng, D.C.3
Oelschlager, D.K.4
Reyes-Fuentes, A.5
Barnes, M.6
Grizzle, W.E.7
-
36
-
-
35648946229
-
Chronic inflammation and oxidative stress in human carcinogenesis
-
DOI 10.1002/ijc.23192
-
Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C., Chronic inflammation and oxidative stress in human carcinogenesis International Journal of Cancer 2007 121 11 2381 2386 (Pubitemid 350022406)
-
(2007)
International Journal of Cancer
, vol.121
, Issue.11
, pp. 2381-2386
-
-
Federico, A.1
Morgillo, F.2
Tuccillo, C.3
Ciardiello, F.4
Loguercio, C.5
-
37
-
-
33845212729
-
Interleukin-1 and cancer progression: The emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
-
Lewis A. M., Varghese S., Xu H., Alexander H. R., Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment Journal of Translational Medicine 2006 4, article 48
-
(2006)
Journal of Translational Medicine
, vol.448
-
-
Lewis, A.M.1
Varghese, S.2
Xu, H.3
Alexander, H.R.4
-
38
-
-
77954551165
-
Why not treat human cancer with interleukin-1 blockade?
-
Dinarello C. A., Why not treat human cancer with interleukin-1 blockade? Cancer and Metastasis Reviews 2010 29 2 317 329
-
(2010)
Cancer and Metastasis Reviews
, vol.29
, Issue.2
, pp. 317-329
-
-
Dinarello, C.A.1
-
39
-
-
0034650771
-
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
-
Reddy B. S., Hirose Y., Lubet R., Steele V., Kelloff G., Paulson S., Seibert K., Rao C. V., Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis Cancer Research 2000 60 2 293 297 (Pubitemid 30070754)
-
(2000)
Cancer Research
, vol.60
, Issue.2
, pp. 293-297
-
-
Reddy, B.S.1
Hirose, Y.2
Lubet, R.3
Steele, V.4
Kelloff, G.5
Paulson, S.6
Seibert, K.7
Rao, C.V.8
|